Drugs in Context
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.2 | Q3 | 35.4% | 0.659 | Q2 | 70.9% |
| 2024 | 2.8 | Q2 | 55.8% | 0.775 | Q2 | 76.9% |
| 2023 | — | — | 0.811 | Q2 | 80.1% | |
| 2022 | — | — | 0.845 | Q2 | 82.0% | |
| 2021 | — | — | 1.130 | Q1 | 89.0% | |
| 2020 | — | — | 1.262 | Q1 | 89.8% | |
| 2019 | — | — | 0.848 | Q2 | 81.8% | |
| 2018 | — | — | 0.921 | Q2 | 82.3% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1745-1981
ISSN
1740-4398
region
Western Europe
coverage
2006-2008, 2012-2026